GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $29,445,000 | +4703.4% | 432,378 | +2152.0% | 0.24% | +4760.0% |
Q2 2022 | $613,000 | -6.8% | 19,200 | +1.1% | 0.01% | +25.0% |
Q1 2022 | $658,000 | +18.3% | 19,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $556,000 | -21.6% | 19,000 | -31.7% | 0.00% | -20.0% |
Q3 2021 | $709,000 | -56.8% | 27,824 | -40.6% | 0.01% | -50.0% |
Q2 2021 | $1,640,000 | +52.8% | 46,824 | +77.9% | 0.01% | +42.9% |
Q1 2021 | $1,073,000 | +84.4% | 26,324 | +119.4% | 0.01% | +75.0% |
Q3 2019 | $582,000 | -7.8% | 12,000 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $631,000 | -0.6% | 12,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $635,000 | +28.8% | 12,000 | 0.0% | 0.00% | +33.3% |
Q4 2018 | $493,000 | -7.3% | 12,000 | -14.3% | 0.00% | 0.0% |
Q3 2018 | $532,000 | +2.3% | 14,000 | +21.7% | 0.00% | 0.0% |
Q2 2018 | $520,000 | +53.8% | 11,500 | +64.3% | 0.00% | +50.0% |
Q1 2018 | $338,000 | – | 7,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |